Increased glutamate in CSF and plasma of patients with HIV dementia

Neurology

Volumn 57, Issue 4, 2001, Pages 671-675

  Ferrarese, C ^a,b   Aliprandi, A ^a   Tremolizzo, L ^a   Stanzani, L ^a   De Micheli, A ^b   Dolara, A ^b   Frattola, L ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EXCITOTOXIN; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ATROPHY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DEGENERATIVE DISEASE; DEMENTIA; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATHOGENESIS; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0035964407     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.4.671     Document Type: Article

References (22)

1. Dementia in AIDS patients: Incidence and risk factors. Multicenter AIDS Cohort Study
2. Nomenclature and research case definition for neurologic manifestation of human immunodeficiency virus-type 1 (HIV-1) infection
3. Neuropathological changes in early HIV dementia
4. Neocortical damage during HIV infection
5. Evidence of apoptotic cell death in HIV encephalitis
6. Human immunodeficiency virus type 1 Tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity
7. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: Protection by memantine
8. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity
9. Elevated glutamate in cerebrospinal fluid of patients with HIV dementia
10. Elevated cerebrospinal glutamate levels in patients with HIV dementia
11. Bicaudate ratio as a measure of caudate volume in MRI
12. Bicaudate diameter the most specific and simple CT parameter in the diagnosis of Huntington disease
13. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
14. Assessment of reliability and biological significance of glutamate levels in cerebrospinal fluid
15. Relevance of glutamate levels in the CSF of patients with HIV-1-associated dementia complex
16. Elevated plasma glutamate levels in colorectal carcinoma patients and in patients with acquired immunodeficiency syndrome (AIDS)
17. HIV-1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting the uptake and stimulating the release of the amino acid
18. The spectrum of liver damage in AIDS
19. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy
20. Differential vulnerability of hippocampus, basal ganglia, and prefrontal cortex to long-term NMDA excitotoxicity
21. Neuronal injury associated with HIV-1: Approaches to treatment
22. Riluzole: A potential therapy for HIV dementia?